All Episodes
Conversations in Lung Cancer Research — 71 episodes
Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
The Evolving Landscape of BRAF-Mutated NSCLC in Australia
Thymic Cancer: The Lesser-Known Thoracic Tumours
A/Prof Surein Arulananda: A Masterclass in Career Growth
TOGA ASM 2026: Program Review
ALK TKI Sequencing in the Australian Landscape
Professor Michael Millward: Clinical Insights in Lung Cancer Research
Dr. Megan Sanders: From Science to TOGA Leadership
Lung Cancer Research: 2025 Year in Review
New and Emerging Practice Standards in ES-SCLC
Exploring Lung Cancer Care and Research in New Zealand
Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
Prof. Anna Nowak: A Journey from Oncology Lab to Leadership
CNS Progression in Lung Cancer: A Practical Conversation on Best Practices
A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
Lessons from Fellowships and building Clinical Trials Units
Prof Wendy Cooper: Journey of a Thoracic Pathologist
Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
The Role of Liquid Biopsy in Modern Oncology
Exploring EGFR Exon 20 Insertion Mutations
From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
Introducing Conversations in Lung Cancer Research - Trailer
Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
NTRK1, 2,3 And Other Rare Mutations In NSCLC
Decoding Perioperative Immunotherapy In NSCLC
Access to New Medicines: Which Surrogate Endpoints Matter
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
Underutilisation of Radiotherapy in Lung Cancer Treatment
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
Lung cancer Screening and Moving from Concept to Roll Out
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
Nature and nurture: lung cancer risk and implications for future screening
Operability in Stage III NSCLC
NSCLC and KRAS Mutations
Treatment Considerations in ALK-Positive NSCLC
Celebrating Female Leadership in Medical Research
Brain metastases in NSCLC
NGS panels in lung cancer
Lung Cancer Screening and its impact on patient care in Australia
The Management of Stage III NSCLC
The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
Accelerating Progress in Oncogene-driven Lung Cancer
Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
Practical smoking cessation advice for health care providers
Consider Every Trial as a TeleTrial
EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
The need for a National Clinical Quality Registry in Lung Cancer
ALK treatment considerations in NSCLC
Stigma and Nihilism In Lung Cancer : A Call to Action
Challenging the Lung Cancer Stigma
The Value of Comprehensive Genomic Profiling in Lung Cancer
Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
Long Term Survivorship: Thriving with Metastatic Lung Cancer
Women and Lung Cancer: The Rising Tide
Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer
Lung cancer screening works!
Dreaming of Better Treatments for Mesothelioma
Lung Cancer Careers: Preceptorship Reflections
Cancer won't wait: A Cancer Australia Perspective
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
Redefining Survival In Lung Cancer: Meet Alexandra
Improving Survival In Oncogene Driven Lung Cancer